EYEN Eyenovia Inc

Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10

Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10

Company to host an investor conference call and webcast at 4:30pm EDT

NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi™ (tropicamide+phenylephrine ophthalmic spray) for mydriasis and developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced that the Company will release financial results for the second quarter ended June 30, 2023 on Thursday, August 10, 2023, after the markets close. Following the release, Eyenovia management will host a conference call and webcast at 4:30 p.m. EDT to review the financial and operating results.

Participants should dial 1-877-407-9039 (domestic) or 1-201-689-8470 (international) and referencing conference ID 13739696.

To access the Call me™ feature, which avoids having to wait for an operator, click .

A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at .

After the live webcast, the event will be archived on Eyenovia’s website for one year.

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is a commercial stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. Eyenovia is currently focused on the commercialization of Mydcombi (tropicamide + phenylephrine ophthalmic spray) for mydriasis, as well as the ongoing late-stage development of medications in the Optejet device for presbyopia and myopia progression (partnered with Bausch+Lomb). For more information, visit .

The Eyenovia Corporate Information slide deck may be found at .

Eyenovia Contact:

Eyenovia, Inc.

John Gandolfo

Chief Financial Officer

Eyenovia Investor Contact:

Eric Ribner

LifeSci Advisors, LLC



(646) 751-4363

Eyenovia Media Contact:

Eyenovia, Inc.

Norbert Lowe

Vice President, Commercial Operations





EN
07/08/2023

Underlying

EYENEyenovia Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Eyenovia Inc

 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Announces Institutional Volatility Income Vault Built on...

Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol Productizes On-chain Strategy Designed to Enhance Yield and Ecosystem Rewards through Gated Institutional Access LAGUNA HILLS, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today announced that it has engaged with the Rysk protocol (“Rysk”) to launch a new institutional-grade, on-chain yield-enhancement vault native to the HyperEVM. Through this vault, Hyperion DeFi and its institutional partners will be able to utilize HYPE Liquid Staki...

February 4, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Issues Letter to Shareholders

Hyperion DeFi Issues Letter to Shareholders LAGUNA HILLS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today issued a letter to shareholders from its Chief Executive Officer, Hyunsu Jung. To the shareholders of Hyperion DeFi, Inc.: Let me start by expressing my sincere gratitude to those sharing in our journey to become the leading Hyperliquid-native Decentralized Finance (“DeFi”) company. As I formally step into the CEO role at Hyperion DeFi, I wanted to take a moment to reflect on what we’ve built in 2025 and what we l...

January 12, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer

Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer Board Confirms Leadership Team to Execute 2026 Strategic Priorities Company Also Appoints Robert Rubenstein as General Counsel LAGUNA HILLS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today announced that its Board of Directors has appointed Hyunsu Jung as Chief Executive Officer, effective immediately. Mr. Jung’s appointment marks an important milestone in the Company’s leadership evolution as it advances its strategic priorities for 2026. Mr. Jung joined ...

January 5, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Announces Receipt of Kinetiq Airdrop, Partnership with N...

Hyperion DeFi Announces Receipt of Kinetiq Airdrop, Partnership with Native Markets, and Purchase of 150,000 Additional HYPE Receives 1,918,478.78 KNTQ in the Token Generation Event Airdrop, Plus Right to Earn Additional Yield on 28,888 HYPE Staked by the Company Partnership with Native Markets to Support Hyperliquid-Aligned USDH Stablecoin Generates Additional Yield for 300,000 HYPE Staked by the Company Announces 150,000 HYPE purchase resulting in 1,862,195 Gross HYPE Tokens Owned by the Company LAGUNA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD...

December 4, 2025 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record...

Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million Management Initiates Q4’25 Adjusted Revenue(3) Guidance of 31% to 43% Q-o-Q Growth Over 13 Million HYPE Tokens Staked to Hyperion’s Validator as of October 31, 2025 Ramping Business Lines Expected to Achieve Positive Operating Cash Flows in 2026 LAGUNA HILLS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE, today...

November 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch